Pharmaceuticals giant smashes profits thanks to rise in Cancer and Heart Disease since 2021.
Pfizer has released expected record sales forecast thanks to a sudden rise in cases of Cancer and Heart Disease. The forecast predicts overall sales will surpass their previous record in 2021/22 made by sales of their Covid-19 vaccines.
Now Pfizer are riding high on the unexpected sales boom of both Cancer and heart disease drugs. This bombshell announcement came on July 30, 2024 with Pfizer.
Pfizer raked in $14.9 billion in Q1 2024 alone made partly by repeat business of the C-19 vaccine but boosted by a sudden jump in other sectors, up by 11%, as cases of Heart Disease and Cancer surge.
New Heart Inflammation drug helps boost sales.
in December 2021 Pfizer bought immuno-inflammatory firm Arena Pharmaceuticals for $6.7b. The pharmaceutical company had a new product for the treatment of heart conditions such as Myocarditis and Pericarditis which have been on the rise since that time.
Related
Increased Risk of Myocarditis known by Pfizer Before Jan 2022 Leaked Documents Reveal
"Onset was typically within several days after mRNA COVID-19 vaccination.."
Kommentare